CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −6,237 | 12,475 | ||
| 2026-09-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −6,481 | 6,481 | ||
| 2026-09-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −9,991 | 0 | ||
| 2026-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +3,932 | 31,629 | ||
| 2026-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +2,558 | 34,187 | ||
| 2026-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +2,362 | 36,549 | ||
| 2026-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +2,644 | 39,193 | ||
| 2026-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes 10b5-1 | −5,531 | $79.28 | $438K | 33,662 |
| 2026-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Restricted Share Unit 10b5-1 | +3,650 | 3,650 | ||
| 2026-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Share Option 10b5-1 | +14,600 | 14,600 | ||
| 2026-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −2,644 | 7,931 | ||
| 2026-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −2,362 | 4,725 | ||
| 2026-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −2,558 | 2,557 | ||
| 2026-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −3,932 | 0 | ||
| 2026-08-19 | Quart Barry D Director | Gift | −2,600 | 12,745 | ||
| 2026-08-01 | Levy Richard S Director | Option exercise | +403 | 22,359 | ||
| 2026-08-01 | Levy Richard S Director | Grant or award · Restricted Share Units | +403 | 403 | ||
| 2026-08-01 | Levy Richard S Director | Option exercise · Restricted Share Units | −403 | 0 | ||
| 2026-07-29 | Cole G Bradley Director | Sale | −3,673 | $81.43 | $299K | 11,672 |
| 2026-07-29 | Cole G Bradley Director | Gift | −4,500 | 7,172 |
Page 9 of 74 · 1,467 trades